Andrew A. Kanner

Tel Aviv University — Israel

Medicine · Health Sciences

35h-index9.8kcitations133works1.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Glioma Diagnosis and Treatment(69), Brain Metastases and Treatment(44), Meningioma and schwannoma management(25), Vascular Malformations Diagnosis and Treatment(11), Cerebrospinal fluid and hydrocephalus(10)

Publications132 total

Characterization of the tumor microbiome of brain metastases and glioblastoma reveals tumor-type-specific and location-specific microbial signatures
Nature Cancer·2025
Brain tumor classification from FFPE samples using nanopore methylation sequencing
NAR Cancer·2025Open Access
Let the light in: influence of fluorescence-guided resection with 5-aminolevulinic acid on surgical outcomes, extent of resection, and survival in subventricular zone glioblastoma
Journal of neurosurgery·2025
“Hope” Drives Quality of Life in Patients With Brain Metastases, But, the “Hope Center” Remains Elusive: An Analysis of NRG-CC003
International Journal of Radiation Oncology*Biology*Physics·2025Open Access
Long-term impact of bevacizumab for the treatment of brain radiation necrosis
Journal of Neuro-Oncology·2025· 1 cited
The impact of brain MRI screening on stage IV NSCLC patients: A real world look at guidelines based care
Journal of the Neurological Sciences·2025· 4 cited
P17.17.A RADIATION NECROSIS INDUCED BY STEREOTACTIC RADIOTHERAPY. LONG TERM IMPACT OF BEVACIZUMAB
Neuro-Oncology·2024Open Access
Stem the blood flow: beneficial impact of bevacizumab on survival of subventricular zone glioblastoma patients
Journal of Neuro-Oncology·2024· 3 citedOpen Access
Hope drives quality of life in patients with brain metastases, but the hope center remains elusive: An analysis of NRG-CC003.
Journal of Clinical Oncology·2024· 1 cited
Effect of bevacizumab on refractory meningiomas: 3D volumetric growth rate versus response assessment in neuro-oncology criteria
Neuro-Oncology Advances·2024Open Access
A phase II, open-label, single-arm trial of pembrolizumab for recurrent meningioma and solitary fibrous tumor
Neuro-Oncology Advances·2024· 3 citedOpen Access
Is serum‐derived exosomal <scp>hTERT</scp> transcript a marker of oncogenic activity in primary brain tumors? An exploratory study
Cancer Medicine·2023· 6 citedOpen Access
P14.09.B IS BLOOD-DERIVED EXOSOMAL HTERT TRANSCRIPT A MARKER OF ONCOGENIC ACTIVITY IN PRIMARY BRAIN TUMORS? AN EXPLORATORY STUDY
Neuro-Oncology·2023Open Access
[THERAPEUTIC OPTIONS FOR BRAIN OLIGOMETASTASES: COMPARISON BETWEEN SURGICAL RESECTION, STEREOTACTIC RADIOSURGERY, WHOLE BRAIN RADIATION THERAPY AND COMBINED MODULES IN RELATION TO SURVIVAL, FUNCTION AND OTHER CONSIDERATIONS].
PubMed·2023
Reciprocal interactions between innate immune cells and astrocytes facilitate neuroinflammation and brain metastasis via lipocalin-2
Nature Cancer·2023· 76 citedOpen Access
Significant Systemic Insulin Resistance is Associated With Unique Glioblastoma Multiforme Phenotype
Clinical Pathology·2023· 1 citedOpen Access
P12.01.B Systemic metabolic features associated with significant insulin resistance in diabetes mellitus type 2 patients are related to the presence of gemistocytes in glioblastoma
Neuro-Oncology·2022Open Access
Detection of gene mutations and gene–gene fusions in circulating cell‐free DNA of glioblastoma patients: an avenue for clinically relevant diagnostic analysis
Molecular Oncology·2021· 47 citedOpen Access
Author response for "Detection of gene mutations and gene–gene fusions in circulating cell‐free DNA of glioblastoma patients: an avenue for clinically relevant diagnostic analysis"
2021Open Access
Height in adolescence as a risk factor for glioma subtypes: a nationwide retrospective cohort study of 2.2 million subjects
Neuro-Oncology·2021· 7 citedOpen Access
page 1 of 7Next →

Frequent Co-authors

Zvi Ram(18), Roger Stupp(8), Sophie Taillibert(8), Benjamin W. Corn(8), Tal Shahar(7), Deborah T. Blumenthal(7), Eilon D. Kirson(6), Yoram Palti(6), Gene H. Barnett(6), Steven A. Toms(5), Frank S. Lieberman(5), Jay‐Jiguang Zhu(5), Andreas F. Hottinger(5), Uri Weinberg(5), Lisa A. Kachnic(5), Felix Bokstein(5), David M. Steinberg(4), Ahmed Idbaïh(4), Karen Fink(4), Chae‐Yong Kim(4)